Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yara Abdou

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Breast Cancer|January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical TrialsDario Trapani, Qingchun Jin, Kathy D Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 25, 2024
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic StatusSarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Annals of Surgical Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Practical Radiation Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Clinical Breast Cancer|May 8, 2025
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer SymposiumKomal Jhaveri, Carey K Anders, Aditya Bardia, et al.
Journal of the National Cancer Institute|July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)Yara Abdou, Jess Hoag, William E Barlow, et al.
Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Breast Cancer|January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical TrialsDario Trapani, Qingchun Jin, Kathy D Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 25, 2024
Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic StatusSarah C Van Alsten, Matthew R Dunn, Alina M Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Annals of Surgical Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Practical Radiation Oncology|September 16, 2025
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice GuidelineRachel B Jimenez, Yara Abdou, Penny Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Clinical Breast Cancer|May 8, 2025
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer SymposiumKomal Jhaveri, Carey K Anders, Aditya Bardia, et al.
Journal of the National Cancer Institute|July 16, 2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)Yara Abdou, Jess Hoag, William E Barlow, et al.
Journal of the National Cancer Institute|December 10, 2024
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trialYara Abdou, William E Barlow, Julie R Gralow, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Pageof 5